NSAIDs and kidney

Journal of Association of Physicians of India

Volumn 52, Issue AUG, 2004, Pages 632-640

  Ejaz, P ^a   Bhojani, K ^a   Joshi, V R ^a  

^a P D HINDUJA NATIONAL HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT;

ACUTE KIDNEY FAILURE; CHEMICALLY INDUCED DISORDER; CHRONIC KIDNEY FAILURE; COMPARATIVE STUDY; DOSE RESPONSE; FEMALE; HUMAN; INCIDENCE; INTERSTITIAL NEPHRITIS; KIDNEY FUNCTION TEST; MALE; PATHOPHYSIOLOGY; PROGNOSIS; REVIEW; RISK ASSESSMENT;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; INCIDENCE; KIDNEY FAILURE, ACUTE; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TESTS; MALE; NEPHRITIS, INTERSTITIAL; PROGNOSIS; RISK ASSESSMENT;

EID: 18744383666     PISSN: 00045772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (90)

1. Perazella MA, Tray K. Selective cyclooxygenase-2 inhibitors: a pattern of nephrotoxicity similar to traditional non-steroidal anti-inflammatory drugs. Am J Med 2001;111:64-7.
2. Garella S, Matarese RA. Renal effects of prostaglandins and clinical adverse effects of nonsteroidal anti-inflammatory agents. Medicine 1984;63:165-81.
3. Clive DM, Stoff JS. Renal syndromes associated with nonsteroidal anti-inflammatory drugs. N Eng J Med 1984;310:563-72.
4. Sedor JR, Davidson EW, Dunn MJ. Effects of nonsteroidal anti-inflammatory drugs in healthy subjects. Am J Med 1986;81:58-70.
5. Levin ML. Patterns of tubulointerstitial damage associated with non-steroidal anti-inflammatory drugs. Semin Nephrol 1988;8:55-61.
6. Kleinknecht D. Interstitial nephritis, the nephritic syndrome and chronic renal failure secondary to non-steroidal antiinflammatory drugs. Semin Nephrol 1995;15:228-35.
7. Whelton A. Nephrotoxicity of nonsteroidal antiinflammatory drugs: Physiologic foundations and clinical implications. Am J Med 1999;106:13S-24S.
8. Blackshear JL, Napier JS, Davidman M, Stillman MT. Renal complications of nonsteroidal anti-inflammatory drugs: Identification and monitoring of those at risk. Semin Arthritis Rheum 1985;14:165-75.
9. Tse WY, Adu D. Non-steroidal anti-inflammatory drugs and the kidney. In : Davison AM, Cameron S, Grunfeld JP, Kerr DNB, Ritz E, Winerals CG, eds, Oxford textbook of nephrology, 2nd Edition, Oxford publications, 1998:1145-56.
10. Calvo-Alen J, Angeles De Cos M, Rodriguez-Valverde V, Escalladv R, Florez J, Arias M. Subclinical renal toxicity. J Rheumatol 1994;214:1742-47.
11. Gault MH, Barrett B J. Analgesic nephropathy. Am J Kidney Dis 1998;32:35-360.
12. 2 formation. N Eng J Med 1988;319:689-98,761-67.
13. 2 on chloride transport across the rabbit thick ascending limb of Henle; selective inhibitors of the medullary portion. J Clin Inv 1979;64:495-502.
14. 2 across the isolated perfused rabbit collecting tubule. J Clin Invest 1977;59:1099-104.
15. Orloff JB, Handler JS, Bergestrom S. Effects of prostaglandin (PGE1) on the permeability response of the toad bladder to vasopressin, theophylline and adenosine3′, 5'-monophosphate. Nature 1985;205:397-98.
16. Anderson RJ, Berl T, McDonald KM, Schrier RW. Evidence for an in vivo antagonism between vasopressin and prostaglandins in the mammalian kidney. J Clin Invest 1975;56:420-26.
17. Schrier RW, Henrich WL. Nonsteroidal anti-inflammatory drugs: caution still indicated. JAMA 1984:251:1301-02.
18. Delmas PD. Nonsteroidal anti-inflammatory drugs and renal function. Br J Rheumatol 1995;Supp1:25-28.
19. Fox DA., Jick H. Nonsteroidal anti-inflammatory drugs and renal disease. JAMA 1984;251:1299-1300.
20. Evans JM, McGregor E, McMahon AD, McGilchrist MM, Jones MC, White G, McDevitt DG, MacDonald TM. Nonsteroidal anti-inflammatory drugs and hospitalization for acute renal failure. QJM 1995;88:551-7.
21. Perez Gutthann S, Garcia Rodriguez LA, Raiford DS, Duque Oliart A, Ris Romeu J. Nonsteroidal anti-inflammatory drugs and the risk of hospitalization for acute renal failure. Arch Intern Med 1996;156:2414.
22. Griffin MR, Yared A, Ray WA. Nonsteroidal anti-inflammatory drugs and acute renal failure in elderly persons. Am J Epidemiol 2000;151:488-96.
23. Baraldi A, Ballestri M, Rapana R, Lucchi L, et al. Acute renal failure of medical type in an elderly population. Nephrol Dial Transplant 1998;13Suppl 7:25-9
24. Adams DH, Homer AJ, Micheal J, McKonkey B, Bacon P, Adu D. Nonsteroidal anti-inflammatory drugs and renal failure. Lancet 1986;1:57-59.
25. Brezin JH, Katz SM, Schwartz AB, Chinitz JL. Reversible renal failure and nephrotic syndrome associated with non-steroidal antiinflammatory drugs. N Eng J Med 1979;301:1271-73.
26. Postishil'lu A. Pathomorphology of kidney lesions induced by non-steroidal anti-inflammatory drugs. Arkh Patol 1995;57:70-4.
27. Warren GV, Korbet SM, Schwartz MM, Lewis EJ. Minimal change glomerulopathy associated with non-steroidal antiinflammatory drugs. Am J Kidney Dis 1989;14:530-1.
28. Marasco WA, Gikas PW, Azziz-Baumgartner R, Hyzy R, Eldredge CJ, Stross J. Ibuprofen-associated renal dysfunction. Pathophysiologic mechanisms of acute renal failure, hyperkalemia, tubular necrosis and proteinuria. Arch Intern Med 1987;147:2107-16.
29. Ravnskov V. Glomerular, tubular and interstitial nephritis associated with non-steroidal anti-inflammatory drugs. Evidence of a common mechanism. Br J Clin Pharmacol 1999;47:203-10.
30. Perazella MA, Buller GK. Can Ibuprofen cause acute renal failure in a normal individual? A case of acute overdose. Am J Kidney Dis 1991;18:600-2.
31. Whelton A, Scott H, Stout RL. Effects of misoprostol on nonsteroidal anti-inflammatory drug-induced renal insufficiency in patients with stable chronic renal failure: A double-blind, crossover study. Am J Ther 1995;2:858-63.
32. Whelton A, Stout RL, Spilman PS, Klassen DK. Renal effects of Ibuprofen, Piroxicam and Sulindac in patients with asymptomatic renal failure. A prospective, randomized cross over comparison. Ann Intern Med 1990;12:568-76.
33. Finkelstein A, Fraley DS, Stachura I, Feldman HA, Gandy DR, Bourke E. Fenprofen nephropathy : lipoid nephrosis and interstitial nephritis. A possible T lymphocyte disorder. Am J Med 1982;72:81.
34. Kleinknecht D, Landias P, Goldfarb B. Analgesic and nonsteroidal anti-inflammatory. A prospective study. Clin Nephrol 1986;25:275-81.
35. Atta MG, Whelton A. Acute renal papillary necrosis induced by ibuprofen. Am J Therapeut 1997;4:55-60.
36. Husserl FE, Lange RK, Kantrow CM Jr. Renal papillary necrosis and pyelonephritis accompanying fenoprofen therapy. JAMA 1979;242:1896-98.
37. Robertson CE, Ford MJ, Van Someren V, et al. Mefenamic acid nephropathy. Lancet 1980;2:1208-10.
38. Shah GM, Muhalwas KK, Winer RL. Renal papillary necrosis due to ibuprofen. Arthritis Rheum 1981;24:1208-10.
39. Morales A, Steyn J. Papillary necrosis following phenylbutazone ingestion. Arch Surg 1971;103:420-21.
40. Furuichi K, Wada T, Iwata Y, Sakai N, et al. Administration of FR167653, a new anti-inflammatory compound, prevents renal ischemia/reperfusion injury in mice. Nephrol Dial Transplant 2002;17:399-407.
41. Goebel KM, Mueller-Brodmann W. Reversible overt nephropathy with Henoch-Schonlein purpura due to piroxicam. Br Med J 1982;284:311.
42. Malik S, Arthurton I, Griffiths ID. Mefenamic acid nephropathy. Lancet 1980;2:746.
43. Lam G, Kjellstand C. Sudden catastrophic renal failure from non-steroidal anti-inflammatory drugs. J Am Soc Nephrol 1994;3:399.
44. Mc Donald GA, Du Bose TD, Molony DA, Verian R. Nephrotoxicity of nonsteroidalantiinflammatory drugs. Lancet 1994;344:515.
45. Schwarz A, Krause PH, Kunzendrof V, Keller F, Distler A. The outcome of acute interstitial nephritis: risk factors for the transition from acute to chronic interstitial nephritis. Clin Nephrol 2000;54:179-90.
46. Nanra RS. Renal papillary necrosis and chronic interstitial nephritis with nonsteroidal anti-inflammatory drugs. Comparison with the amylase syndrome. Kidney Int 1989;35:752.
47. Atkinson LK, Goodship THJ, Ward MK. Acute renal failure associated with the acute pyelonephritis and consumption of nonsteroidal anti-inflammatory drugs. Br Med J 1868;292:97-98.
48. Hawksworth GM, Stewart VC, Bell JA, whiting PH. Human renal lipooxygenases. Potential involvement in papillary necrosis. J Am Soc Nephrol 1994;5:923.
49. Fernandez-Tome MC, Sterin-speziale NB: Short and long term treatment with indomethacin causes phospholipid alteration: A possible explanation for indomethacin nephrotoxicity. Pharmacology 1994;48:341-48.
50. Gurwitz JH, Avorn J, Bohn RL, et al. Initiation of antihypertensive treatment during nonsteroidal antiinflammatory drug therapy. JAMA 1994; 272:781-86.
51. Kunico GS, Neilson EG, Haverty T. Mechanisms of tubulointerstitial fibrosis. Kidney Int 1991; 39:550-556.
52. Pernerger TV, Whelton PK, Klag MJ. Risk of kidney failure associated with the use of acetaminophen, aspirin and nonsteroidal anti-inflammatory drugs. N Eng J Med 1994;331:1675-1679.
53. Emkey RD, Mills JA. Aspirin and analgesic nephropathy. JAMA 1982;247:55-7.
54. D'Agati V. Does aspirin cause acute or chronic renal failure in experimental animals and humans? Am J Kidney Dis 1996;28:S24-9.
55. Murray T, Stolley PD, Anthony JC, Schirmer MPA, Helper-Smith E, Jeffreys JL. Epidemiologic study of regular analgesic use and end stage renal disease. Ann Intern Med 1988;143:1687-93.
56. Rexrode KM, Buring JE, Glynn RJ, Stamfer MJ, Youngman LD, Gaziano JM. Analgesic use and renal function in men. JAMA 2001;286:315-21
57. Pommer W, Bronder E, Klimpel A, Molzahn M, Helmert U, Greiser E. Regular intake of analgesic mixtures and risk of end stage renal failure. Lancet 1989;1:381.
58. Sandler DP, Burr R, Weinburg CR. Non-steroidal antiinflammatory drugs and the risk of chronic renal disease. Ann Intern Med 1991;115:165-72.
59. Sandler DP, Smith JS, Weinburg CR, Buckalow VM, Dennis VM, Blythe WB, Burgess P. Analgesic use and chronic renal disease. N Eng J Med 1989;320:1238-43.
60. Fored CM, Ejerblad E, Lindblad P, Fryzek JP, et al. Acetaminophen, aspirin and chronic renal failure. N Eng J Med 2001;345:1801-08.
61. Segasothy M, Smad S, Zulfigar A, Bennett WM. Chronic renal disease and papillary necrosis associated with the long term use of non-steroidal anti- inflammatory drugs as the sole or predominant analgesic. Am J Kidney Dis 1994;24:17-24.
62. Segasothy M, Chin GL, Sia KK, Zulfigar A, Samad SA. Chronic nephrotoxicity of anti-inflammatory drugs used in the treatment of arthritis. Br J Rheumatol 1995;34:162-5.
63. Kantachuvesiri S, Kaojarern S, Kitayaporn D, Phanichphant S, et al. Riskfactors between analgesic use and chronic nephropathy in Thailand. Southeast Asian. J Trop Med Public Health 1996;27:350-5.
64. Unsworth J, Struman S, Lunec J, Blake DR. Renal impairment associated with non-steroidal anti-inflammatory drugs. Ann Rheum Dis 1987;46:233-36.
65. Richards IM, Fraser SM, Capell HA, Fox JG, Boulton-Jones JM. A survey of renal function in outpatients with rheumatoid arthritis. Clin Rheumatol 1988;7:267-271.
66. Calvo- Alen J, Angeles De Cos M, Rodriguez-Valverde V, Escalladv R, Florez J, Arias M. Subclinical renal toxicity in rheumatic patients receiving long term treatment with nonsteroidal anti-inflammatory drugs and renal failure. Lancet 1986;1:57-59.
67. Koseki Y, Terai C, Moriguchi M, Vesato M, Kamatani N. a prospective study of renal disease in patients of early rheumatoid arthritis. Ann Rheum Dis 2001;60:327-31.
68. Caspi D, Lubart E, Graff E, Habot B, et al. The effect of minidose aspirin on renal function and uric acid handling in elderly patients. Arthritis Rheum 2000;43:103-8.
69. Pathan E, Gaitonde S, Rajadhyaksha S, Sule A, Mittal G, Joshi VR. A longitudinal study of serum creatinine levels in patients of rheumatoid arthritis on long term NSAID therapy. J Assoc Phy Ind 2003;51:1045-49.
70. Strumer T, Erb A, Keller F, Gunther KP, Brenner H. Determinants of impaired renal function with use of nonsteroidal anti-inflammatory drugs: the importance of half life and other medications. Am J Med 2001;111:521-7.
71. Miller MJS, Bednar MM and Mc Giff JC. Renal metabolism of sulindac: functional implications. Journal of Pharmacology and Experimental. Therapeutics 1984;231:449-56.
72. Mistry CD, Lote CJ, Currie WJ, Vandenburg M, Mallick NP. Effects of sulindac on renal function and prostaglandin synthesis in patients with moderate chronic renal insufficiency. Clin Sci (Lond) 1986;70:501-5.
73. Jeremy JI, Mikhailidis DP, Barradas MA, Kirk RM, Dandona P. The effect of nabumetone and its principal active metabolites on invitro human gastric mucosal prostanoid synthesis and platelet function. Br J Rheumatol 1990;29:116-19.
74. Giannessi D, Lazzerini G, Filipponi P, et al. Effects of nabumetone a new non- steroidal anti-inflammatory drug on urinary prostaglandin excretion in man. Pharmacological Research 1993;28:229-41.
75. Cook ME, Wallin JP, Thakur VD, Kadowitz PJ, Mcnamara DB, Garcia MM, Lipani JA, Poland M. J Rheumatol 1997;24:1137-44.
76. Blackwell E, Loughlin K, Dumler F, Smythe M. Nabumetone associated interstitial nephritis. Pharmacotherapy 1195;15:669-72.
77. Brater DC, Harris C, Redfern JS, Gertz BJ. Renal effects of COX-2-selective inhibitors. Am J Nephrol 2001;21:1-15.
78. Whelton A, Maurath CJ, Verburg KM, Geis GS. Renal safety and tolerability of celecoxib, a novel cyclo-oxygenase-2 inhibitor. Am J Ther 2000;7:151-2.
79. Ahmad SR, Kortepeter C, Brinker A, Chen M, Beitz J. renal failure associated with the use of celecoxib and rofecoxib. Drug Saf 2002;25:537-44.
80. Brater DC. Renal effects of cyclooxygenase-2-selective inhibitors. J Pain Symptom Manage 2002;23:S15-20.
81. Shwartz JI, Vandormael K, Malice MP, Kalyani RN, et al. Comparison of rofecoxib, celecoxib and naproxen on renal function in elderly subjects receiving a normal-salt free diet. Clin Pharmacol Ther 2002;72:50-61.
82. Graham MG. Acute renal failure related to high dose celecoxib. Am J Kidney Dis 2000;35:937-40.
83. Alkhuja S, Menkel RA, Alwarshetty M, Ibrahimbacha AM. Celecoxib -induced non-oliguric acute renal failure. Ann Pharmacother 2002;36:52-54.
84. Demke D, Zhao S, Arellano FM. Interstitial nephritis associated with celecoxib. Lancet 2001;358:1726-7.
85. Alper AB Jr, Meleg-Smith S, Krane NK. Nephrotic syndrome and interstitial nephritis associated with celecoxib. Am J Kidney Dis 2002;40:1086-90.
86. Henao J, Hisammudin I, Nzerue CM, Vasandani G, Hewan-Lowe K. Celecoxib-induced acute interstitial nephritis. Am J Kidney Dis 2002;39:1313-7.
87. Zhao SZ, Reynolds MW, Lejkowith J, Whelton A, Arellano FM. A comparison of renal related adverse drug reactions between rofecoxib and celecoxib, based on the World Health Organization/ Uppsala Monitoring center safety database. Clin Ther 2001;23:1478-91.
88. Whelton A, fort JG, Puma JA, Normandin D et al. Cyclooxygenase-2-specific inhibitors and cardiorenal function: a randomized, controlled trial of celecoxib and rofecoxib in older hypertensive osteoarthritis patients. Am J Ther 2001;8:85-95.
89. Rocha JL, Fernandes-Alonso J. Acute tubulointerstitial nephritis associated with the selective Cox-2 enzyme inhibitor, rofecoxib. Lancet 2001;357:1946-7.
90. Morales E, Mucksavage JJ. Cyclooxygenase-2 inhibitorassociated acute renal failure: case report with rofecoxib and review of the literature. Pharmacotherapy 2002;22:1317-21.